 Impel NeuroPharma Incs NASDAQ: IMPL has priced its previously announced underwritten public offering of 3 million shares at 15.00 per share for gross proceeds of 45 million. The offer price represents a steep discount of 29 from the last close price of 21.13 on Thursday. 